GENB Generate Biomedicines, Inc.
Company Analysis
Latest News
🟢 Generate Biomedicines is trading 10.22% up today amid broader biotech gains
Generate Biomedicines is trading 10.22% higher at $14.56 on October 28, alongside broader biotech strength; no source confirms a specific driver for the...
🟢 Generate Biomedicines is trading 5.6% up in pre-market with no confirmed company-specific catalyst
Generate Biomedicines is trading at $13.94, up +5.55%, as AI-enabled drug-discovery research draws attention; available sources do not confirm this news caused...
🟢 Generate Biomedicines is trading 5% up in after-hours trading amid stronger biotech-sector sentiment
Generate Biomedicines is trading at $13.88, up 5.06%, as biotech-sector sentiment strengthens. - Shares rose 6.96% during the October 27 regular session and...
🟢 Generate Biomedicines is trading 5% up today amid stronger biotech sector sentiment
Generate Biomedicines is trading at $12.97, up 5.06%, in a move that appears consistent with stronger biotech sector sentiment; no confirmed company-specific...
🟢 Generate Biomedicines is trading 6.1% up in pre-market — catalyst unconfirmed
Generate Biomedicines is trading 6.1% up in pre-market at $13.10 on October 27, with no confirmed company-specific catalyst identified. - Its latest listed...
🟢 Generate Biomedicines is trading 5% up today as biotech shares rebounded; no company-specific catalyst identified
Generate Biomedicines is trading at $12.71, up 5.13%, amid a broader biotech rebound; no clear company-specific announcement was found to explain the October...
🔴 Generate Biomedicines is trading 5% down today amid broader biotech and market weakness
Generate Biomedicines is trading 5.28% down at $12.37, alongside weakness in biotech and broader risk-sensitive markets. - XBI is down 2.06%, while the Nasdaq...
🟢 Generate Biomedicines is trading 0.1% up in pre-market
Generate Biomedicines is trading at $13.07, up 0.1% versus the October 15 close of $13.06; no clear company-specific catalyst was identified for the pre-market...
🟢 Generate Biomedicines is trading 5% up in pre-market after Zealand Pharma AI-designed metabolic therapy deal
Generate Biomedicines is trading 5.26% higher at $12.90 in pre-market on October 14 after its October 13 Zealand Pharma partnership to develop AI-designed...
🟢 Generate Biomedicines is trading 5% up in after-hours trading after Zealand Pharma metabolic-disease partnership
Generate Biomedicines is trading at $12.89, up 5.18%, after announcing a Zealand Pharma collaboration to develop AI-designed protein therapeutics for obesity...
🔴 Generate Biomedicines is trading 10.5% down
Generate Biomedicines is trading 10.5% down at $12.39 on October 13, 2026, with no clear company-specific catalyst identified. - A Seeking Alpha analysis of...
🔴 Generate Biomedicines is trading 5% down — specific trigger remains unclear
Generate Biomedicines is trading 5.27% lower at $13.11 on October 13, 2026; the specific trigger remains unclear. - No major company announcement or clearly...
🟢 Generate Biomedicines is trading 5% up today amid biotech-sector strength
Generate Biomedicines is trading at $14.74, up 5.36%, amid positive biotech-sector sentiment. - No new company-specific announcement was found for October 9;...
🟢 Generate Biomedicines is trading 5% up in pre-market
Generate Biomedicines is trading at $14.50, up 5.07% in pre-market on October 2, 2026; no clear catalyst has been identified. - On October 1, the company...
🔴 Generate Biomedicines is trading 4.3% down
Generate Biomedicines is trading at $14.38, down 4.29%, with no clear company-specific explanation identified for the October 1 decline. - The company’s...
🟢 Generate Biomedicines is trading 5% up in pre-market with no clear company-specific catalyst identified
Generate Biomedicines is trading 5.06% higher at $15.78 in pre-market, based on the provided pre-market price context; no clear company-specific catalyst has...
🟢 Generate Biomedicines is trading 5% up in pre-market — no clear catalyst identified
Generate Biomedicines is trading 5.38% higher at $16.25 in pre-market, with no clear catalyst identified for the September 30 move. - Available search results...
🔴 Generate Biomedicines is trading 4.85% down today with no clear catalyst identified
Generate Biomedicines is trading 4.85% lower at $15.21, amid continued biotech and growth-stock pressure, with no clearly confirmed direct catalyst. - It...
🔴 Generate Biomedicines is trading 5% down today amid broad biotech-sector pressure
Generate Biomedicines is trading 5.1% down at $15.68, pressured by broad biotech and growth-stock weakness. - No new company-specific announcement or...
🔴 Generate Biomedicines is trading 4.64% down today with no confirmed catalyst
Generate Biomedicines is trading at $16.65, down 4.64%, with no clearly confirmed catalyst for the decline. - At the Bernstein Healthcare Forum on September...